These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25476970)

  • 1. In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography.
    Comley RA; van der Aart J; Gulyás B; Garnier M; Iavarone L; Halldin C; Rabiner EA
    Neuropharmacology; 2015 May; 92():44-8. PubMed ID: 25476970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A positron emission tomography study to assess binding of lecozotan, a novel 5-hydroxytryptamine-1A silent antagonist, to brain 5-HT1A receptors in healthy young and elderly subjects, and in patients with Alzheimer's disease.
    Raje S; Patat AA; Parks V; Schechter L; Plotka A; Paul J; Langstrom B
    Clin Pharmacol Ther; 2008 Jan; 83(1):86-96. PubMed ID: 17507923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study.
    Lothe A; Boni C; Costes N; Bouvard S; Gorwood P; Lavenne F; Alvarez M; Ryvlin P
    Behav Brain Funct; 2010 Jul; 6():37. PubMed ID: 20609217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study.
    Chou YH; Halldin C; Farde L
    Psychopharmacology (Berl); 2003 Mar; 166(3):234-40. PubMed ID: 12589516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verbal memory and 5-HT1A receptors in healthy volunteers--A PET study with [carbonyl-(11)C]WAY-100635.
    Penttilä J; Hirvonen J; Tuominen L; Lumme V; Ilonen T; Någren K; Hietala J
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):570-7. PubMed ID: 26775837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635.
    Moses-Kolko EL; Price JC; Thase ME; Meltzer CC; Kupfer DJ; Mathis CA; Bogers WD; Berman SR; Houck PR; Schneider TN; Drevets WC
    Synapse; 2007 Jul; 61(7):523-30. PubMed ID: 17447260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
    Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676.
    Varnäs K; Juréus A; Johnström P; Ahlgren C; Schött P; Schou M; Gruber S; Jerning E; Malmborg J; Halldin C; Afzelius L; Farde L
    J Pharmacol Exp Ther; 2016 Sep; 358(3):464-71. PubMed ID: 27402278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
    Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Weissfeld L; Mathis CA; Drevets WC; Wagner A; Hoge J; Ziolko SK; McConaha CW; Kaye WH
    Arch Gen Psychiatry; 2005 Sep; 62(9):1032-41. PubMed ID: 16143735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11C]WAY-100635 and [11C]raclopride.
    Rabiner EA; Gunn RN; Wilkins MR; Sedman E; Grasby PM
    J Psychopharmacol; 2002 Sep; 16(3):195-9. PubMed ID: 12236624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects.
    Stenkrona P; Halldin C; Lundberg J
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1190-8. PubMed ID: 23428337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders.
    Spindelegger C; Lanzenberger R; Wadsak W; Mien LK; Stein P; Mitterhauser M; Moser U; Holik A; Pezawas L; Kletter K; Kasper S
    Mol Psychiatry; 2009 Nov; 14(11):1040-50. PubMed ID: 18362913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.
    du Jardin KG; Jensen JB; Sanchez C; Pehrson AL
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans.
    Mukherjee J; Bajwa AK; Wooten DW; Hillmer AT; Pan ML; Pandey SK; Saigal N; Christian BT
    J Comp Neurol; 2016 May; 524(7):1457-71. PubMed ID: 26509362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar.
    la Fougère C; Böning G; Bartmann H; Wängler B; Nowak S; Just T; Wagner E; Winter P; Rominger A; Förster S; Gildehaus FJ; Rosa-Neto P; Minuzzi L; Bartenstein P; Potschka H; Cumming P
    Neuroimage; 2010 Jan; 49(2):1406-15. PubMed ID: 19796699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET.
    Fink M; Wadsak W; Savli M; Stein P; Moser U; Hahn A; Mien LK; Kletter K; Mitterhauser M; Kasper S; Lanzenberger R
    Neuroimage; 2009 Apr; 45(2):598-605. PubMed ID: 19103294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward brain imaging of serotonin 5-HT1A autoreceptor internalization.
    Zimmer L; Riad M; Rbah L; Belkacem-Kahlouli A; Le Bars D; Renaud B; Descarries L
    Neuroimage; 2004 Jul; 22(3):1421-6. PubMed ID: 15219613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.
    Andrée B; Halldin C; Thorberg SO; Sandell J; Farde L
    Nucl Med Biol; 2000 Jul; 27(5):515-21. PubMed ID: 10962260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.